title: Prolonged changes in plasma concentrations of catecholamine metabolites following a single infusion of an MPTP analog.
abstract: The magnitude and duration of effects of a single intravenous injection of 4'-amino MPTP, an analogue of the dopamine neurotoxin, MPTP, on plasma levels of catechols and normetanephrine were examined in conscious dogs. Plasma samples were collected prior to treatment with intravenous saline or 4'-amino MPTP.2HCl (22.5 mg/kg) and at weekly intervals for six weeks following treatment. Saline treatment had no effect on plasma levels of any of the measured compounds. Following 4'-amino MPTP, plasma DHPG fell to 14% of the pre-injection value and remained decreased for the full 6-week test period, with partial recovery by week 6 to 42% of the pre-injection value. Plasma DOPAC levels fell to 28% of pre-injection values 1 week after treatment with 4'-amino MPTP and showed no evidence of recovery during the 6-week test period. Plasma DOPA fell to 58% of the pre-injection level, while concentrations of the catecholamines NE, EPI, and DA were generally unaffected. The plasma concentration of the O-methylated NE metabolite, normetanephrine, was also unchanged by 4'-amino MPTP treatment. There were no differences in the concentrations of DA, NE or EPI within the adrenal medulla between saline and 4'-amino MPTP treated groups. This pattern of changes in plasma levels of catechols, which is consistent with presynaptic inhibition of MAO within sympathetic terminals, may be a useful indicator of exposure to MPTP-like neurotoxins.
authors: Laboratory of Clinical Science, NIMH, Bethesda, MD 20892.
authors: J N
authors: JN
authors: Johannessen
authors: D S
authors: DS
authors: Goldstein
authors: J
authors: J
authors: Oliver
authors: S P
authors: SP
authors: Markey
mesh_terms: D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000494:pharmacology; D015102:3,4-Dihydroxyphenylacetic Acid / Q000097:blood; D000311:Adrenal Glands / Q000378:metabolism; D000818:Animals; D002395:Catecholamines / Q000097:blood*; D004285:Dogs; D005260:Female; D007275:Injections, Intravenous; D008297:Male; D008734:Methoxyhydroxyphenylglycol / Q000031:analogs & derivatives / Q000097:blood; D009647:Normetanephrine / Q000097:blood; D013564:Sympathetic Nervous System / Q000378:metabolism; D013997:Time Factors
chemical_list: D002395:Catecholamines; D009647:Normetanephrine; D015102:3,4-Dihydroxyphenylacetic Acid; C066728:4'-amino-1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D008734:Methoxyhydroxyphenylglycol; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; C010117:3,4-dihydroxyphenylglycol